BDBM603943 3-Fluoropropyl 2-[6-[[(1S,2S)-2-(hydroxymethyl)cyclopropyl]methoxy]-5-(3-methoxyazetidin-1-yl)pyridine-2-carbonylamino]-2-vinyl-but-3-enoate::US11655243, Example 20

SMILES COC1CN(C1)c1ccc(nc1OC[C@H]1C[C@@H]1CO)C(=O)NC(C=C)(C=C)C(=O)OCCCF

InChI Key InChIKey=OPGLYCOGIIOLBP-UHFFFAOYSA-N

Data  1 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 603943   

TargetCannabinoid receptor 2(Human)
Hoffmann-La Roche

US Patent
LigandPNGBDBM603943(US11655243, Example 20 | 3-Fluoropropyl 2-[6-[[(1S...)
Affinity DataKi:  525nMAssay Description:The affinity of the compounds of the invention for cannabinoid CB1 receptors was determined using recommended amounts of membrane preparations (Perki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/26/2023
Entry Details
Go to US Patent